|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
2
|
Rohatgi PR, Yao JC, Hess K, et al: Outcome
of gastric cancer patients after successful gastrectomy: influence
of the type of recurrence and histology on survival. Cancer.
107:2576–2580. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nashimoto A, Nakajima T, Furukawa H, et
al: Randomized trial of adjuvant chemotherapy with mitomycin,
Fluorouracil, and Cytosine arabinoside followed by oral
Fluorouracil in serosa-negative gastric cancer: Japan Clinical
Oncology Group 9206-1. J Clin Oncol. 21:2282–2287. 2003. View Article : Google Scholar
|
|
4
|
Marrelli D, De Stefano A, de Manzoni G,
Morgagni P, Di Leo A and Roviello F: Prediction of recurrence after
radical surgery for gastric cancer: a scoring system obtained from
a prospective multicenter study. Ann Surg. 241:247–255. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deng JY, Sun D, Liu XY, Pan Y and Liang H:
STAT-3 correlates with lymph node metastasis and cell survival in
gastric cancer. World J Gastroenterol. 16:5380–5387. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsang YH, Lamb A, Romero-Gallo J, et al:
Helicobacter pylori CagA targets gastric tumor suppressor
RUNX3 for proteasome-mediated degradation. Oncogene. 29:5643–5650.
2010. View Article : Google Scholar
|
|
7
|
Ito Y: Runx genes in development and
cancer: regulation of viral gene expression and the discovery of
Runx family genes. Adv Cancer Res. 99:33–76. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito K, Lim AC, Salto-Tellez M, et al:
Runx3 attenuates β-catenin/T cell factors in intestinal
tumourigenesis. Cancer Cell. 14:226–237. 2008.
|
|
9
|
Soong R, Shah N, Peh BK, et al: The
expression of Runx3 in colorectal cancer is associated with disease
stage and patient outcome. Br J Cancer. 100:676–679. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mabuchi M, Kataoka H, Miura Y, et al:
Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates
to the nucleus with runt domain transcription factor 3 (RUNX3) in
response to TGF-beta signal transduction. Biochem Biophys Res
Commun. 398:321–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei D, Gong W, Oh SC, et al: Loss of RUNX3
expression significantly affects the clinical outcome of gastric
cancer patients and its restoration causes drastic suppression of
tumor growth and metastasis. Cancer Res. 65:4809–4816. 2005.
View Article : Google Scholar
|
|
12
|
Li WQ, Pan KF, Zhang Y, et al:
Relationship between Runx3 expression and precancerous gastric
lesions in high-risk population. Beijing Da Xue Xue Bao.
41:348–352. 2009.PubMed/NCBI
|
|
13
|
Li QL, Ito K, Sakakura C, et al: Causal
relationship between the loss of Runx3 expression and gastric
cancer. Cell. 109:113–124. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li WQ, Pan KF, Zhang Y, et al: RUNX3
methylation and expression associated with advanced precancerous
gastric lesions in a Chinese population. Carcinogenesis.
32:406–410. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yano T, Ito K, Fukamachi H, et al: The
RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells
undergoing transforming growth factor beta-induced apoptosis. Mol
Cell Biol. 26:4474–4488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ito K, Liu Q, Salto-Tellez M, et al:
RUNX3, a novel tumor suppressor, is frequently inactivated in
gastric cancer by protein mislocalization. Cancer Res.
65:7743–7750. 2005.PubMed/NCBI
|
|
17
|
Nakanishi Y, Shiraha H, Nishina SI, et al:
Loss of runt-related transcription factor 3 expression leads
hepatocellular carcinoma cells to escape apoptosis. BMC Cancer.
11:32011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Subramaniam MM, Chan JY, Yeoh KG, Quek T,
Ito K and Salto-Tellez M: Molecular pathology of RUNX3 in human
carcinogenesis. Biochim Biophys Acta. 1796:315–331. 2009.PubMed/NCBI
|
|
19
|
Ogasawara N, Tsukamoto T, Mizoshita T, et
al: RUNX3 expression correlates with chief cell differentiation in
human gastric cancers. Histol Histopathol. 24:31–40.
2009.PubMed/NCBI
|
|
20
|
Peng Z, Wei D, Wang L, et al: RUNX3
inhibits the expression of vascular endothelial growth factor and
reduces the angiogenesis, growth, and metastasis of human gastric
cancer. Clin Cancer Res. 12:6386–6394. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang TL, Ito K, Ko TK, et al: Claudin-1
has tumor suppressive activity and is a direct target of RUNX3 in
gastric epithelial cells. Gastroenterology. 138:255–265. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsu PI, Hsieh HL, Lee J, et al: Loss of
RUNX3 expression correlates with differentiation, nodal metastasis,
and poor prognosis of gastric cancer. Ann Surg Oncol. 16:1686–1694.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu HW, Ren F, Chen W and Wang YJ: The
influence of survival analysis on RUNX3 gene expression in the
primary tumor of patients suffering from stomach carcinoma. Cancer
Research on Prevention and Treatment. 2011.(E-pub ahead of
print).
|
|
24
|
Ikeda Y, Saku M, Kishihara F and Maehara
Y: Effective follow-up for recurrence or a second primary cancer in
patients with early gastric cancer. Br J Surg. 92:235–239. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Furukawa H, Imamura H and Kodera Y: The
role of surgery in the current treatment of gastric carcinoma.
Gastric Cancer. 5:13–16. 2002. View Article : Google Scholar
|
|
26
|
Zhang XP, Wang ZL, Tang L, Sun YS, Cao K
and Gao Y: Support vector machine model for diagnosis of lymph node
metastasis in gastric cancer with multidetector computed
tomography: a preliminary study. BMC Cancer. 11:102011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tajima Y, Murakami M, Yamazaki K, et al:
Risk factors for lymph node metastasis from gastric cancers with
submucosal invasion. Ann Surg Oncol. 17:1597–604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park TJ, Han SU, Cho YK, Paik WK, Kim YB
and Lim IK: Methylation of O6-methylguaine-DNA methyltransferase
gene is associated significantly with K-ras mutation, lymph node
invasion, tumor staging, and disease free survival in patients with
gastric carcinoma. Cancer. 92:2760–2768. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Wei X, Guo C, et al: Runx3
suppresses gastric cancer metastasis through inactivation of MM9 by
up-regulation of TIMP-1. Int J Cancer. Dec;2010.(E-pub ahead of
print).
|
